Total Holdings
22
Portfolio diversification across 22 positions
THNR
(NYSEARCA)Amplify Weight Loss Drug & Treatment ETF
$26.54-- (--)
Loading... - Market loading
THNR ETF Holdings: Amplify Weight Loss Drug & Treatment ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$3.94M
Total fund assets
Expense Ratio
0.59%
Annual management fee
Fund Issuer
Amplify Investments
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 27 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 15.46% |
| 2 |  | Novo Nordisk A/S | Stock | 11.24% |
| 3 |  | Regeneron Pharmaceuticals, Inc | Stock | 7.73% |
| 4 |  | Amgen Inc. | Stock | 7.36% |
| 5 | T TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 7.31% |
| 6 | T TYO:4519 | Chugai Pharmaceutical Co., Ltd. | Stock | 6.56% |
| 7 | T TYO:4507 | Shionogi & Co., Ltd. | Stock | 5.91% |
| 8 |  | Merck & Co., Inc. | Stock | 5.72% |
| 9 | S SWX:ROG | Roche Holding AG | Stock | 5.54% |
| 10 |  | AstraZeneca PLC | Stock | 5.28% |
| 11 | L LON:AZN | AstraZeneca PLC | Stock | 4.97% |
| 12 |  | Pfizer Inc. | Stock | 4.97% |
| 13 |  | AbbVie Inc | Stock | 4.82% |
| 14 | T TSE:4507 | Shionogi & Co. Ltd. | Stock | 4.68% |
| 15 | H HKG:1801 | Innovent Biologics, Inc. | Stock | 4.51% |
| 16 | H HKG:1093 | CSPC Pharmaceutical Group Limited | Stock | 4.33% |
| 17 |  | Arrowhead Pharmaceuticals, Inc. | Stock | 3.96% |
| 18 |  | Hims & Hers Health, Inc | Stock | 3.66% |
| 19 | C CO:ZEAL | Zealand Pharma A/S | Stock | 3.28% |
| 20 |  | Scholar Rock Holding Corp | Stock | 2.17% |
| 21 | C CPH:ZEAL | Zealand Pharma A/S | Stock | 1.99% |
| 22 |  | Viking Therapeutics, Inc. | Stock | 1.50% |
| 23 | H HKG:3933 | The United Laboratories International Holdings Limited | Stock | 1.08% |
| 24 | K KRX:128940 | Hanmi Pharm. Co., Ltd. | Stock | 1.04% |
| 25 | M MUTF:AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | Stock | 0.99% |
| 26 | J JNGHF | Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H | Stock | 0.88% |
| 27 | N NMFQS:AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | Cash | 0.85% |